Peoplescomm ClinicCommunity Health & Clinical Research

Early Detection and Slowing Progression of Chronic Kidney Disease in Primary Care

Chronic Kidney Disease (CKD) is frequently asymptomatic in its early stages (Stages 1–3), yet early detection provides a critical window to halt or significantly retard progression toward end-stage renal disease (ESRD). Combining estimated glomerular filtration rate (eGFR) with urine albumin-to-creatinine ratio (uACR) is essential for accurate KDIGO risk stratification.

KDIGO Risk Grid: eGFR and Albuminuria Categories

eGFR Category (mL/min/1.73m²) A1: Normal to Mild (< 30 mg/g) A2: Moderate (30–300 mg/g) A3: Severe (> 300 mg/g)
G1 (≥ 90) Low Risk Moderate Risk High Risk
G2 (60–89) Low Risk Moderate Risk High Risk
G3a (45–59) Moderate Risk High Risk Very High Risk
G3b (30–44) High Risk Very High Risk Very High Risk
G4 (15–29) Very High Risk Very High Risk Very High Risk

Peoplescomm Clinic Medical & Clinical Advisory Board

Authored and reviewed by licensed clinical healthcare practitioners and biomedical researchers. All diagnostic biomarker criteria, clinical trial citations, and preventive wellness guidelines are cross-referenced against peer-reviewed medical literature.

Seeking Personalized Clinical Care?

Consult with our multidisciplinary physicians to develop an individualized wellness protocol.

Book Consultation